The National Institute for Health and Care and Excellence (NICE) has published a Technology Appraisal for Tirzepatide (Mounjaro) for managing overweight and Obesity (TA1026) on 23rd December 2024.
Read the ICB public statement in response to launch of NICE TA on Tirzepatide here
Loading...